Osteoboost

Therapeutic Devices · Redwood City, CA · Founded 2014 · Privately Held (backing)

Developer of a medical device designed to provide relief from osteopenia. Osteoboost is based in Redwood City, CA and was founded in 2014. It was valued at $45 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $17.8 million across 1 recorded round; the latest was an accelerator round in Jan 2024.

PMV mark · valuation
$45.0M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$17.8M
Last round
Accelerator/Incubator
Jan 2024
What is Osteoboost worth?
$45.0MPrivateMarketView mark · Oct 2026

Valued at $45.0M at its later-stage round, Apr 2026. Nothing has traded since.

Free account
More of Osteoboost with a free account
  • ·The complete investor list: 20 names
  • ·Watch Osteoboost: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Osteoboost funding history

1 rounds
DateRoundRaisedPost-money
Jan 2024Accelerator/Incubator—▮
Unlock post-money valuations

Membership and data by Private Market View

Osteoboost valuation

Osteoboost was valued at $45 million at its later-stage round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Osteoboost raised?

Osteoboost has raised $17.8 million in total; 1 of its rounds is on record. The most recent was an accelerator round in Jan 2024.

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy Osteoboost shares, reporting $600,000 sold to 10 investors, per SEC Form D filings (most recent May 2026).

Comparable companies

Comparable therapeutic devices names by valuation on PrivateMarketView: Materna Medical ($110 million), Luminate Medical ($74.5 million) and NasaClip ($16 million).

How Osteoboost's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Osteoboost, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Osteoboost

What is Osteoboost worth?
Osteoboost is valued at $45.0M as of Oct 2026. Valued at $45.0M at its later-stage round, Apr 2026. Nothing has traded since.
How much has Osteoboost raised?
Osteoboost has raised $17.8M in total funding across 1 recorded rounds.
When did Osteoboost last raise?
Osteoboost last raised in Jan 2024 (Accelerator/Incubator).